In mice. Not in clinical trials yet. Oncolytic viruses are a popular research topic these days:
Engineered oncolytic herpes virus inhibits ovarian and breast cancer metastases
Engineered oncolytic herpes virus inhibits ovarian and breast cancer metastases
"Numerous laboratories worldwide are using viruses as more specific weapons against cancer cells, called oncolytic viruses", says Campadelli-Fiume, Professor of Microbiology and Virology. "Safety concerns prevailed so far, and all oncolytic herpesviruses now in clinical trials are debilitated viruses, effective only against a fraction of tumors. We were the first to obtain a herpes virus reprogrammed to enter HER-2-positive tumor cells, unable to infect any other cell, yet preserves the full-blown killing capacity of the wild-type HSV".